Fingerprint
Dive into the research topics of 'Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions
Sheena Bhalla, Douglas Tremblay, John Mascarenhas
Research output: Contribution to journal › Review article › peer-review
9
Scopus
citations